期刊文献+

血清YKL-40水平对冠心病合并糖尿病患者的影响研究 被引量:4

Effect of serum YKL-40 on diabetic patients with coronary heart disease
下载PDF
导出
摘要 目的观察冠心病合并糖尿病患者血清YKL-40水平及与相关影响因素分析,探讨血清水平对冠心病合并糖尿病患者的影响。方法选取在我科住院治疗患者120例,随机分为正常对照组、单纯冠心病组及冠心病合并糖尿病组,各40例,采取酶联免疫吸附法(Elisa)测定血清YKL-40水平,线性回归相关分析相关影响因素。结果与正常对照组比较,冠心病组及冠心病合并糖尿病组YKL-40水平升高明显,差异有统计学意义(P〈0.05);冠心病合并糖尿病组YKL-40水平与年龄、FPG、TG、HbAIC等因素存在相关陛,差异具有统计学意义(P〈0.05)。结论YKL-40可作为评估冠脉病变程度及血管壁炎症反应程度的重要指标;年龄、FPG、TG、HbAIC是其影响因素。 Objective To observe serum level of YKL-40 in diabetic patients with coronary heart disease ( CHD ) and analyzed the related influencing factors, and to explore the effect of YKL-40 on those patients. Methods 120 patients which were randomly divided into normal control group, CHD group and group of CHD diabetes mellitus. Enzyme- linked immunosorbent assay ( EIISA ) was used to determine serum YKL-40 levee linear regression analysis was used to analyze the related factors. Results As compared with the normal group, YKL-40 level increased obviously in CHD group and the group of CHD and diabetes, with a statistical significance ( P〈 0.05 ) ; YKL-40 level was related with age, FPG, TG, and HbAIC in the group of CHD and diabetes, with a statistical significance ( P〈 0.05 ). Conclusions YKL-40 can used as an important indicator for assessing the severity of coronary lesions and the degree of vascular wall inflammatory reaction. Age, FPG, TG, and HbAIC are the influencing factors of YKL-40 level.
作者 张生友
出处 《国际医药卫生导报》 2012年第15期2242-2244,共3页 International Medicine and Health Guidance News
关键词 YKL-40 冠心病 糖尿病 YKL-40 Coronary heart disease Diabetes mellitus
  • 相关文献

参考文献4

二级参考文献37

  • 1毛节明,王广.动脉粥样硬化与炎症[J].中国循环杂志,2006,21(6):405-406. 被引量:20
  • 2李莉,郭明秋,苏天璐,王玉洁,谭海艳,殷晓婕.血清超敏C反应蛋白测定在冠心病中的临床应用[J].中国实验诊断学,2007,11(2):190-191. 被引量:15
  • 3Ridker P M.High-sensitivity C-reactive protein and cardiovascular risk; rationale for screening and primary prevention[J].Am J Cardiol,2003,92(4B):17-22.
  • 4Lehrke M,Millington S C,Lefterova M,et al.CXCL16 is a marker of inflammation,atherosclerosis,and acute coronary syndromes in humans[J].J Am Coil Cardiol,2007,49(4):442-449.
  • 5Boot R G,van Achterberg T A,van Aken B E,et al.Strong induction of members of the chitinase family of proteins in atherosclerosis; chitotriosidase and human cartilage gp-39 expressed in lesion macrophages[J].Arteripscler Thromb Vasc Biol,1999,19(3):687-694.
  • 6Rathcke C N,Johansen J S,Vestergaard H.YKL-40,a biomarker of inflammation,is elevated in patients with type 2 diabetes and is related to insulin resistance[J].Inflamm Res,2006,55(2):53-59.
  • 7Fach E M,Carulacan L A,Gao J,et al.In vitro biomarker discovery for atherosclerosis by proteomics[J].Mol Cell Proteomics,2004,3(12):1200-1210.
  • 8Wilbanks A,Zondlo S C,Murphy K,et al.Expression cloning of the STRL33/ BONZO/TYMSTR ligand reveals elements of CC,CXC,and CX3C chemokines[J].J Immunol,2001,166 (8):5145-5154.
  • 9Wang Y,Ripa R S,Johansen J S,et al.YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease[J].Scand Cardiovasc J,2008,42(5):295-302.
  • 10Shimaoka T,Nakayama T,Hieshima K,et al.Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain[J].J Biol Chem,2004,279(26):26807-26810.

共引文献42

同被引文献52

  • 1Sigurdardottir V,Fagerberg B,Hulthe J.Preclinical atherosclerosis and inflammation in 61-year-old men with newly diagnosed diabetes and established diabetes[J].Diabetes Care,2004,27(4):880-884.
  • 2Arai H.Platelet-activating factor acetylhydrolase[J].Prostaglandins Other Lipid Mediat,2002,68-69:83-94.
  • 3Schaloske RH,Dennis EA.The phospholipase A2 superfamily and its Group numbering system[J].Bilchim Biophys Acta,2006,1761 (11):1246-1259.
  • 4Gazi I,Lourida ES,Filippatos T,et al.Lipoprotein-associated phospholipase A2 activity is a marker of small,dense LDL particles in human plasma[J].Clin Chem 2005,51(12):2264-2273.
  • 5Johansen JS,Jensen BV,Roslind A,et al.Serum YKL-40,a new prognostic biomarker in cancer patients[J].Cancer Epidemiol Biomarkers Prev,2006,15(2):194-202.
  • 6Rathcke CN,Johansen JS,Vestergaard H.YKL-40,a biomarker of inflammation,is elevated in patients with type 2 diabetes and is related to insulin resistance[J].Inflamm Res,2006,55(2):53-59.
  • 7stergaard C,Johansen JS,Benfield T,et al.YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis[J].Clin Diagn Lab Immunol,2002,9(3):598-604.
  • 8Johansen JS,H(o)yer PE,Larsen LA,et al.YKL-40 protein expression in the early developing human musculoskeletal system[J].J Histochem Cytochem,2007,55(12):1213-1228.
  • 9Lp-PLA(2) Studies Collaboration,Thompson A,Gao P,et al.Lipoprotein-associated phospholipaseA(2) and risk of coronary disease,stroke,and mortality:collaborative analysis of 32 prospective studies[J].Lancet,2010,375(9725):1536-1544.
  • 10Blake GJ,Dada N,Fox JC,et al.Aprospective evaluation of lipoprotein-associated phospholipaseA(2) levels and the risk of future cardiovascular events in women[J].J Am Coll Cardiol,2001,38 (5):1302-1306.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部